About I3 Strategy
I3 Strategy is a company based in Philadelphia (United States) founded in 2018. It operates as a B2B. I3 Strategy offers products and services including Patient/Community Insight Discovery, Community Engagement Planning, and Clinical Trial Recruiting. I3 Strategy operates in a competitive market with competitors including Curatio healthcare, Evaluate, Kineticos, J+D Forecasting and Cello Health Advantage, among others.
- Headquarter Philadelphia, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of I3 Strategy
I3 Strategy offers a comprehensive portfolio of products and services, including Patient/Community Insight Discovery, Community Engagement Planning, and Clinical Trial Recruiting. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Uncover insights to develop strategies for underserved patient groups.
Plan executions to ensure awareness and access to therapeutics.
Bridge gaps in diverse patient recruiting for trials.
Funding Insights of I3 Strategy
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by I3 Strategy
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - I3 Strategy
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
I3 Strategy Comparisons
Competitors of I3 Strategy
I3 Strategy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Curatio healthcare, Evaluate, Kineticos, J+D Forecasting and Cello Health Advantage, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Market research services for biopharma sector are provided.
|
|
| domain | founded_year | HQ Location |
Pharmaceutical market intelligence and forecasting solutions are provided by Evaluate.
|
|
| domain | founded_year | HQ Location |
Invests in early-stage life sciences companies for innovation, expertise, and growth.
|
|
| domain | founded_year | HQ Location |
Pharmaceutical forecasting services are provided for global and local markets.
|
|
| domain | founded_year | HQ Location |
Provider of health care data analytics services
|
|
| domain | founded_year | HQ Location |
Provider of market research projects
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about I3 Strategy
When was I3 Strategy founded?
I3 Strategy was founded in 2018.
Where is I3 Strategy located?
I3 Strategy is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
What does I3 Strategy do?
i3 Strategy Partners helps pharmaceutical and biotech firms understand and connect with hard-to-reach communities, such as racial minorities, LGBTQ individuals, and rural residents. They offer services including patient insight discovery, community engagement planning, and clinical trial recruiting to improve health equity. Operating across the US, they leverage expertise to enhance market reach and ensure inclusive healthcare access for all populations.
Who are the top competitors of I3 Strategy?
I3 Strategy's top competitors include Curatio healthcare, Cello Health Advantage and MedPanel.
What products or services does I3 Strategy offer?
I3 Strategy offers Patient/Community Insight Discovery, Community Engagement Planning, and Clinical Trial Recruiting.